Huaxia Competitors

301267 Stock

20.18 0.81 3.86%

Huaxia Eye Hospital competes with China Longyuan, PetroChina, Bank of China, Guangxi Guiguan, and Yantai North; as well as few others. The company operates under Health Care Providers & Services sector and is part of Health Care industry. Analyzing Huaxia Eye competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Huaxia Eye to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Huaxia Eye Correlation with its peers.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Huaxia Eye competition on your existing holdings.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
16.34	21.42	26.50

Details

Intrinsic

Valuation

Low	Real	High
16.39	21.47	26.56

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Huaxia Eye. Your research has to be compared to or analyzed against Huaxia Eye's peers to derive any actionable benefits. When done correctly, Huaxia Eye's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Huaxia Eye Hospital.

Huaxia Eye Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Huaxia Eye and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Huaxia and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Huaxia Eye Hospital does not affect the price movement of the other competitor.

	001289	601857	601988	600236	605198	600025	300600	301177
001289		0.1	0.31	-0.01	0.57	-0.56	0.78	0.76	001289
601857	0.1		0.54	0.59	0.2	0.48	0.28	0.31	601857
601988	0.31	0.54		0.67	0.64	-0.3	0.65	0.66	601988
600236	-0.01	0.59	0.67		0.48	0.12	0.39	0.35	600236
605198	0.57	0.2	0.64	0.48		-0.59	0.77	0.83	605198
600025	-0.56	0.48	-0.3	0.12	-0.59		-0.57	-0.57	600025
300600	0.78	0.28	0.65	0.39	0.77	-0.57		0.92	300600
301177	0.76	0.31	0.66	0.35	0.83	-0.57	0.92		301177
	001289	601857	601988	600236	605198	600025	300600	301177

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

High positive correlations

301177	+ 0.92	300600
301177	+ 0.83	605198
300600	+ 0.78	001289
300600	+ 0.77	605198
301177	+ 0.76	001289
600236	+ 0.67	601988

High negative correlations

600025	- 0.59	605198
301177	- 0.57	600025
300600	- 0.57	600025
600025	- 0.56	001289
600025	- 0.3	601988
600236	- 0.01	001289

Risk-Adjusted Indicators

There is a big difference between Huaxia Stock performing well and Huaxia Eye Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Huaxia Eye's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
001289	2.17	0.33	0.13	(1.07)	2.05	(2.77)	4.24	(2.98)	16.59
601857	1.31	0.15	0.06	(7.24)	1.82	(1.65)	3.55	(2.03)	17.17
601988	1.02	0.22	0.16	1.41	0.95	(1.29)	2.67	(1.98)	7.70
600236	1.27	0.12	0.05	(1.18)	1.99	(1.24)	2.83	(2.50)	13.85
605198	2.74	0.51	0.13	(3.54)	3.15	(2.92)	6.21	(4.28)	19.98
600025	1.25	(0.12)	0.00	(8.70)	0.00	0.00	2.17	(2.59)	10.45
300600	2.34	0.48	0.13	2.27	3.00	(2.52)	3.88	(5.09)	20.86
301177	2.52	0.44	0.14	2.21	2.65	(3.02)	6.17	(5.27)	23.31

Unable to evaluate fundamental data of [001289.SHE, 601857.SHG, 601988.SHG, 600236.SHG, 605198.SHG, 600025.SHG, 300600.SHE, 301177.SHE] at this time. Please try again later

All Fundamental Data

Huaxia Eye Competitive Analysis

The better you understand Huaxia Eye competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Huaxia Eye's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Huaxia Eye's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	301267	001289	601857	601988	600236	605198	600025	300600	301177
	3.86 20.18 Huaxia	1.58 16.79 China	2.88 8.58 PetroChina	1.90 5.36 Bank	0.59 6.79 Guangxi	0.72 27.65 Yantai	1.37 9.65 Huaneng	5.06 7.50 Changshu	5.27 23.55 DR
Market Volatility (90 Days Market Risk)	Not too volatile	Not too volatile	Somewhat reliable	Not too volatile	Somewhat reliable	Not too volatile	Not too volatile	Slightly risky	Not too volatile
Market Performance (90 Days Performance)	Modest	OK	Weak	OK	Insignificant	OK	Very Weak	OK	OK
Odds of Financial Distress (Probability Of Bankruptcy)	Low	Below Average	Low	Low	Below Average	Low	Low	Low	Low
Current Valuation (Equity Enterprise Value)	Under Valued	Over Valued	Over Valued	Under Valued	Over Valued	Over Valued	Fairly Valued	Fairly Valued	Fairly Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available
Trade Advice (90 Days Macroaxis Advice)	Strong Hold	Hold	Strong Hold	Buy	Hold	Cautious Hold	Strong Hold	Strong Hold	Strong Hold
Net Asset	N/A	229.26 B	2.75 T	32.43 T	47.28 B	2.61 B	195.24 B	1.17 B	7.53 B
Profit Margin	0.13	0.16	0.0543	0.44	0.24	0.19	0.33	-0.0757	0.0097
EBITDA	820.9 M	23.24 B	496.11 B	N/A	5.58 B	268.01 M	18.22 B	(25.76 M)	(105.4 M)
Operating Margin	0.18	0.29	0.0896	0.53	0.45	0.17	0.57	-0.26	-0.0603
Current Valuation	14.82 B	228.5 B	1.54 T	5.88 T	73.71 B	7.43 B	285.13 B	2.11 B	5.24 B
Price To Book	3.04	1.97	1.02	0.6	2.56	3.75	2.35	2.39	1.58
Retained Earnings	N/A	43.18 B	914.38 B	1.13 T	4.36 B	2.07 B	18.24 B	158.45 M	1.41 B
Beta	0.67	0.56	0.81	0.29	-0.02	0.094	0.22	1.02	1.05
Number Of Employees	7.61 K	8.75 K	375.8 K	306.93 K	3.52 K	1.02 K	5.04 K	450	3.2 K
Shares Outstanding	840 M	5.04 B	161.92 B	210.77 B	7.88 B	270.54 M	18 B	294.23 M	400.01 M
Cash Flow From Operations	N/A	13.88 B	456.6 B	816.45 B	4.08 B	(29.85 M)	17.06 B	26.19 M	36.97 M
Annual Yield	0.0045	0.0122	N/A	N/A	N/A	0.0079	N/A	N/A	0.0201
Total Debt	N/A	26.69 B	38.98 B	29.68 T	8.46 B	80.72 M	8.14 B	68.67 M	390 M
Return On Equity	0.0946	0.0712	0.11	0.0889	0.11	0.0931	0.12	-0.0202	0.0024
Return On Asset	0.0562	0.033	0.0564	0.0075	0.0451	0.0537	0.0399	-0.0278	-0.0094
Book Value Per Share	6.96	8.66	8.14	7.99	2.15	7.75	3.22	3.14	15.71
Total Asset	N/A	229.26 B	2.75 T	32.43 T	47.28 B	2.61 B	195.24 B	1.17 B	7.53 B
Target Price	39.75	18.66	10.36	5.04	7.63	N/A	10.19	19.5	20.74
Last Dividend Paid	0.11	0.22	0.44	0.24	N/A	0.15	0.18	N/A	0.5
Shares Owned By Institutions	5.19	0.24	1.14	1.48	1.7	0.58	1.65	2.71	0.29
Market Capitalization	19.98 B	111.35 B	1.51 T	1.44 T	54.7 B	8.12 B	175.5 B	2.2 B	9.94 B
Price To Earnings To Growth	N/A	1.2	0.28	3.06	N/A	N/A	N/A	N/A	N/A
Price To Sales	4.25	3.02	0.5	2.7	5.85	6.65	7.09	9.35	6.27
Net Income	N/A	6.25 B	161.14 B	231.9 B	1.23 B	255.52 M	7.64 B	(23.13 M)	68.96 M
Earnings Per Share	0.63	0.66	0.88	0.74	0.27	0.68	0.43	-0.06	0.03
Shares Owned By Insiders	84.28	97.4	94.62	94.2	93.54	92.65	92.27	91.5	91.19
Revenue	4.09 B	37.64 B	3.01 T	621.92 B	8.09 B	876.1 M	23.46 B	196.17 M	2.18 B
Working Capital	N/A	(26.45 B)	(30.49 B)	N/A	(9.93 B)	1.67 B	(24.7 B)	553.53 M	5.34 B
Gross Profit	1.55 B	28.7 B	1.03 T	502.99 B	5.35 B	176.79 M	11.03 B	96.71 M	2.57 B
Day Typical Price	20.49	16.97	8.52	5.34	6.8	27.72	9.56	7.61	23.99
Accumulation Distribution	264774.0	205477.0	6.5 M	7.2 M	217816.0	47150.98	2 M	177264.0	98281.52
Daily Balance Of Power	(0.78)	(0.47)	0.96	0.6667	0.25	(0.23)	0.3421	(0.98)	(0.97)
Period Momentum Indicator	(0.81)	(0.27)	0.24	0.1	0.04	(0.20)	0.13	(0.40)	(1.31)
Rate Of Daily Change	0.96	0.98	1.03	1.02	1.01	0.99	1.01	0.95	0.95
Day Median Price	20.64	17.06	8.49	5.33	6.81	27.76	9.52	7.67	24.21
Price Action Indicator	(0.87)	(0.41)	0.21	0.085	N/A	(0.21)	0.2	(0.37)	(1.31)
Coefficient Of Variation	1229.29	896.17	1336.13	599.72	1477.47	714.51	(1,479)	655.41	794.1
Mean Deviation	3.02	2.17	1.31	1.02	1.27	2.74	1.25	2.34	2.52
Jensen Alpha	0.3778	0.3272	0.1497	0.2179	0.1214	0.5103	(0.12)	0.4803	0.4371
Total Risk Alpha	0.2432	0.2337	0.087	0.1809	0.0633	0.399	(0.17)	0.3903	0.3368
Sortino Ratio	0.086	0.1302	0.0592	0.1597	0.0456	0.1332	N/A	0.1312	0.14
Downside Variance	17.72	5.21	4.53	1.54	4.42	13.19	N/A	12.4	8.94
Standard Deviation	4.86	2.96	2.13	1.39	1.91	3.69	1.67	3.25	3.59
Kurtosis	7.06	2.42	7.76	1.4	4.77	1.32	2.04	2.67	3.2
Potential Upside	7.47	4.24	3.55	2.67	2.83	6.21	2.17	3.88	6.17
Treynor Ratio	1.2	(1.07)	(7.24)	1.41	(1.18)	(3.54)	(8.70)	2.27	2.21
Maximum Drawdown	38.27	16.59	17.17	7.7	13.85	19.98	10.45	20.86	23.31
Variance	23.61	8.76	4.53	1.93	3.64	13.65	2.78	10.54	12.87
Market Risk Adjusted Performance	1.21	(1.06)	(7.23)	1.42	(1.17)	(3.53)	(8.69)	2.28	2.22
Risk Adjusted Performance	0.0728	0.0957	0.0656	0.1364	0.0595	0.1187	(0.05)	0.1285	0.1076
Skewness	0.7122	0.6511	(0.55)	0.5359	(0.20)	(0.04)	0.4225	0.1112	0.7795
Semi Deviation	3.8	2.05	1.82	0.954	1.99	3.15	N/A	3.0	2.65
Information Ratio	0.0745	0.1004	0.0593	0.1429	0.0503	0.131	(0.09)	0.1424	0.1167
Value At Risk	(4.15)	(2.98)	(2.03)	(1.98)	(2.50)	(4.28)	(2.59)	(5.09)	(5.27)
Expected Short fall	(3.50)	(2.77)	(1.65)	(1.29)	(1.24)	(2.92)	N/A	(2.52)	(3.02)
Downside Deviation	4.21	2.28	2.13	1.24	2.1	3.63	N/A	3.52	2.99
Semi Variance	14.45	4.22	3.33	0.9101	3.96	9.95	N/A	9.01	7.03

Huaxia Eye Competition Performance Charts

Five steps to successful analysis of Huaxia Eye Competition

Huaxia Eye's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Huaxia Eye Hospital in relation to its competition. Huaxia Eye's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Huaxia Eye in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Huaxia Eye's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Huaxia Eye Hospital, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Huaxia Eye position

In addition to having Huaxia Eye in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Money Market Funds Thematic Idea Now

Money Market Funds

Funds or Etfs investing in various types of short-term (less than one year) fixed income instruments of high-quality and liquidity. The Money Market Funds theme has 38 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Money Market Funds Theme or any other thematic opportunities.

View All Next

Launch

Other Information on Investing in Huaxia Stock

Huaxia Eye financial ratios help investors to determine whether Huaxia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Huaxia with respect to the benefits of owning Huaxia Eye security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC